In NSCLC cell and xenograft models, SIRPαD1-Fc treatment stimulated autophagic flux, and combining CD47 blockade with autophagy inhibitors enhanced cancer cell killing through a mechanism dependent on ATG5, ATG7, and Beclin 1 [240]. This evidence concerns the gene CD47 and cancer.